Cargando…

Clinical presentation at first heart failure hospitalization does not predict recurrent heart failure admission

AIMS: There are limited data on whether clinical presentation at first heart failure (HF) hospitalization predicts recurrent HF events. We aimed to assess predictors of recurrent HF hospitalizations in mild HF patients with an implantable cardioverter defibrillator or cardiac resynchronization thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosztin, Annamaria, Costa, Jason, Moss, Arthur J., Biton, Yitschak, Nagy, Vivien Klaudia, Solomon, Scott D., Geller, Laszlo, McNitt, Scott, Polonsky, Bronislava, Merkely, Bela, Kutyifa, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695168/ https://www.ncbi.nlm.nih.gov/pubmed/28960867 http://dx.doi.org/10.1002/ehf2.12157

Ejemplares similares

Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block
por: Biton, Yitschak, et al.
Publicado: (2015)

Prognostic Importance of Defibrillator‐Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure
por: Biton, Yitschak, et al.
Publicado: (2019)

Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events
por: Szepietowska, Barbara, et al.
Publicado: (2016)

Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience
por: Kutyifa, Valentina, et al.
Publicado: (2014)

Role of Right Ventricular Global Longitudinal Strain in Predicting Early and Long-Term Mortality in Cardiac Resynchronization Therapy Patients
por: Nagy, Vivien Klaudia, et al.
Publicado: (2015)

Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients
por: Kosztin, Annamaria, et al.
Publicado: (2016)

Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trial
por: Merkely, Béla, et al.
Publicado: (2023)

Need for pacing in patients who qualify for an implantable cardioverter‐defibrillator: Clinical implications for the subcutaneous ICD
por: Kutyifa, Valentina, et al.
Publicado: (2020)

De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis
por: Kosztin, Annamaria, et al.
Publicado: (2017)

Baseline clinical characteristics of heart failure patients with reduced ejection fraction enrolled in the BUDAPEST‐CRT Upgrade trial
por: Merkely, Béla, et al.
Publicado: (2022)

Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients
por: Nagy, Klaudia Vivien, et al.
Publicado: (2018)

Predicting the survival benefit of cardiac resynchronization therapy with defibrillator function for non-ischemic heart failure—Role of the Goldenberg risk score
por: Merkel, Eperke D., et al.
Publicado: (2023)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)
por: Aktas, Mehmet K., et al.
Publicado: (2020)

Predictive value of global longitudinal strain by left ventricular ejection fraction
por: Medvedofsky, Diego, et al.
Publicado: (2023)

Long-term single-centre large volume experience with transseptal endocardial left ventricular lead implantation
por: Gellér, László, et al.
Publicado: (2019)

Lateral left ventricular lead position is superior to posterior position in long‐term outcome of patients who underwent cardiac resynchronization therapy
por: Behon, Anett, et al.
Publicado: (2020)

Outcome by Sex in Patients With Long QT Syndrome With an Implantable Cardioverter Defibrillator
por: Younis, Arwa, et al.
Publicado: (2020)

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2017)

Sex Differences in the Risk of First and Recurrent Ventricular Tachyarrhythmias Among Patients Receiving an Implantable Cardioverter-Defibrillator for Primary Prevention
por: Saxena, Shireen, et al.
Publicado: (2022)

Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death
por: Kutyifa, Valentina, et al.
Publicado: (2018)

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
por: Goldenberg, Ido, et al.
Publicado: (2023)

Models for Heart Failure Admissions and Admission Rates, 2016 through 2018
por: Kruse, Clemens Scott, et al.
Publicado: (2020)

The Role of Ambulatory Heart Failure Clinics to Avoid Heart Failure Admissions
por: He, Jessica, et al.
Publicado: (2019)

Admission hyponatraemia as heart failure events predictor in patients with acute heart failure
por: Sarastri, Yuke, et al.
Publicado: (2023)

Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial
por: Merkely, Bela, et al.
Publicado: (2017)

Risk factors for ventricular tachyarrhythmic events in patients without left bundle branch block who receive cardiac resynchronization therapy
por: Younis, Arwa, et al.
Publicado: (2021)

Sex differences in one-year recurrence and all-cause mortality following catheter ablation of ventricular tachycardia in structural heart disease
por: Tóth, Patrik, et al.
Publicado: (2022)

Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients
por: Wang, Meng, et al.
Publicado: (2022)

The role of local impedance drop in the acute lesion efficacy during pulmonary vein isolation performed with a new contact force sensing catheter—A pilot study
por: Szegedi, Nándor, et al.
Publicado: (2021)

Emergency Heart failure Mortality Risk Grade may help to reduce heart failure admissions
por: van Hattem, N. E., et al.
Publicado: (2022)

Effects of COVID-19 on heart failure admissions
por: Chouairi, Fouad, et al.
Publicado: (2023)

Clinical and financial impact of sleep disordered breathing on heart failure admissions
por: Khayat, Rami N., et al.
Publicado: (2023)

Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score
por: Tokodi, Márton, et al.
Publicado: (2020)

Heart Failure Re-Admission: Measuring the Ever Shortening Gap between Repeat Heart Failure Hospitalizations
por: Bakal, Jeffrey A., et al.
Publicado: (2014)

Implementation of a heart failure educational intervention for patients with recent admissions for acute decompensated heart failure
por: Stahlman, Sarah, et al.
Publicado: (2023)

Confirm Rx insertable cardiac monitor for primary atrial fibrillation detection in high‐risk heart failure patients (Confirm‐AF trial)
por: Aktas, Mehmet K., et al.
Publicado: (2022)

Zero fluoroscopy ablation for atrioventricular nodal reentrant tachycardia and typical atrial flutter is equally safe and effective with EnSite NavX, Carto3, and Rhythmia mapping systems
por: Piros, Katalin, et al.
Publicado: (2023)

Serum Neprilysin and Recurrent Admissions in Patients With Heart Failure
por: Núñez, Julio, et al.
Publicado: (2017)

EFFECTS OF COVID-19 ON HEART FAILURE ADMISSIONS IN NYC
por: Friedman, Ari, et al.
Publicado: (2021)

Baseline characteristics of patients with heart failure and preserved ejection fraction at admission with acute heart failure in Saudi Arabia
por: Abohammar, Samah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pbu42f84tit7nafphnjf8i65ie